SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-052758
Filing Date
2020-10-01
Accepted
2020-10-01 19:13:15
Documents
2
Period of Report
2020-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3641
2 POA DOCUMENT poa.txt EX-24.3_939396 3351
  Complete submission text file 0001209191-20-052758.txt   8386
Mailing Address C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110 WALTHAM MA 02451
Business Address
Morrison Briggs (Reporting) CIK: 0001654430 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39575 | Film No.: 201217605

Mailing Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142
Business Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142 617-425-9200
Oncorus, Inc. (Issuer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations